BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30485654)

  • 1. The use of sclerotherapy with polidocanol foam in the treatment of second-degree haemorrhoidal disease - a video vignette.
    Lobascio P; Minafra M; Laforgia R; Giove C; Trompetto M; Gallo G
    Colorectal Dis; 2019 Feb; 21(2):244-245. PubMed ID: 30485654
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined rubber band ligation with 3% polidocanol foam sclerotherapy (ScleroBanding) for the treatment of second-degree haemorrhoidal disease: a video vignette.
    Bracchitta S; Bracchitta LM; Pata F
    Colorectal Dis; 2021 Jun; 23(6):1585-1586. PubMed ID: 33660907
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of video-guided sclerotherapy with 3% polidocanol foam for symptomatic second-degree haemorrhoidal disease - a video vignette.
    Skowronski A; Diaco E; Trompetto M; Gallo G
    Colorectal Dis; 2020 Sep; 22(9):1198-1199. PubMed ID: 32180308
    [No Abstract]   [Full Text] [Related]  

  • 4. Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: Three-year follow-up of a multicentre, single arm, IDEAL phase 2b trial.
    Gallo G; Picciariello A; Pietroletti R; Novelli E; Sturiale A; Tutino R; Laforgia R; Moggia E; Pozzo M; Roveroni M; Bianco V; Realis Luc A; Giuliani A; Diaco E; Naldini G; Trompetto M; Perinotti R; D'Andrea V; Lobascio P
    Colorectal Dis; 2023 Mar; 25(3):386-395. PubMed ID: 36268758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial.
    Moser KH; Mosch C; Walgenbach M; Bussen DG; Kirsch J; Joos AK; Gliem P; Sauerland S
    Int J Colorectal Dis; 2013 Oct; 28(10):1439-47. PubMed ID: 23775099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerotherapy using 2 % polidocanol foam in the treatment of hemorrhoidal disease - a single-center experience.
    Figueiredo LM; Bordalo Ferreira F; Rafael MA; Oliveira AM
    Rev Esp Enferm Dig; 2022 Mar; 114(3):185-186. PubMed ID: 34517712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerotherapy with 3% polidocanol foam: revolutionizing outpatient treatment in patients with haemorrhoidal disease.
    Gallo G; Ronconi M; Trompetto M
    Updates Surg; 2021 Oct; 73(5):2029-2030. PubMed ID: 33660166
    [No Abstract]   [Full Text] [Related]  

  • 8. Intracavitary Foam Sclerotherapy in Dissecting Cellulitis of the Scalp.
    Aboul-Fettouh N; Silapunt S; Mays S; Nguyen T
    Dermatol Surg; 2021 Sep; 47(9):1317-1319. PubMed ID: 34448768
    [No Abstract]   [Full Text] [Related]  

  • 9. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sclerotherapy with polidocanol in children with internal hemorrhoids.
    Watanabe T; Ohno M; Tahara K; Tomonaga K; Ogawa K; Takezoe T; Fuchimoto Y; Fujino A; Kanamori Y
    Pediatr Int; 2021 Jul; 63(7):813-817. PubMed ID: 33045763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary Experience With More Stable Polidocanol Foam in Sclerotherapy of Head and Neck Venous Malformations.
    Chen AW; Liu SH; Huang YY; Wang T
    Dermatol Surg; 2018 Nov; 44(11):1421-1426. PubMed ID: 29933299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Endoscopic Sclerotherapy Using Polidocanol for Small Bowel Hemangioma.
    Aoyama T; Fukumoto A; Shigita K; Asayama N; Mukai S; Nagata S
    Intern Med; 2020 Jul; 59(14):1727-1730. PubMed ID: 32238724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polidocanol versus phenol in oil injection sclerotherapy in treatment of internal hemorrhoids: A randomized controlled trial.
    Mishra S; Sahoo AK; Elamurugan TP; Jagdish S
    Turk J Gastroenterol; 2020 May; 31(5):378-383. PubMed ID: 32519957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Craniofacial venous malformations treated by percutaneous sclerotherapy using polidocanol: a single-center experience.
    Grieb D; Meila D; Greling B; Jacobs C; Hechtner M; Schlunz-Hendann M; Brassel F
    Acta Radiol; 2019 May; 60(5):593-601. PubMed ID: 30111191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polidocanol Plus Glucose Versus Glucose Alone for the Treatment of Telangiectasias: Triple Blind, Randomised Controlled Trial (PG3T).
    Bertanha M; Yoshida WB; Bueno de Camargo PA; Moura R; Reis de Paula D; Padovani CR; Sobreira ML
    Eur J Vasc Endovasc Surg; 2021 Jan; 61(1):128-135. PubMed ID: 32778489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sclerotherapy of hemorrhoids].
    Badon A
    Phlebologie; 1980; 33(4):613-6. PubMed ID: 7454830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic venous ulcers: experience in six patients treated with terminal interruption of the reflux source (TIRS) TIRS: effective option for the treatment of venous ulcers.
    Mendieta-Eckert M; Azpiazu-Macho JL; Lambea-Crespo R
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):e433-e435. PubMed ID: 28342202
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of lidocaine on postoperative analgesia of endoscopic rubber band ligation combined with injection sclerotherapy for treatment of internal hemorrhoids: A retrospective study (with video).
    Xu W; Xia G; Dong L; Zhu Y
    Arab J Gastroenterol; 2024 May; 25(2):165-169. PubMed ID: 38403495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Evidence-Based Review of Off-Label Uses of Polidocanol.
    Ebrahimi SRS; Enamzadeh E; Babaei H
    Curr Clin Pharmacol; 2017; 12(4):223-230. PubMed ID: 29473522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.